- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5513 - 1,4-Benzodiazepines, e.g. diazepam
Patent holdings for IPC class A61K 31/5513
Total number of patents in this class: 1529
10-year publication summary
|
113
|
112
|
167
|
138
|
134
|
157
|
144
|
107
|
111
|
55
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20802 |
40 |
| Bristol-myers Squibb Company | 4748 |
32 |
| Alkermes Pharma Ireland Limited | 254 |
30 |
| Jazz Pharmaceuticals Research UK Limited | 256 |
24 |
| Enanta Pharmaceuticals, Inc. | 421 |
23 |
| Neurelis, Inc. | 58 |
22 |
| Nippon Chemiphar Co., Ltd. | 225 |
22 |
| GW Research Limited | 147 |
16 |
| Ovid Therapeutics Inc | 179 |
16 |
| Boehringer Ingelheim International GmbH | 4483 |
14 |
| Novartis AG | 10178 |
12 |
| Pfizer Inc. | 3404 |
12 |
| Aquestive Therapeutics, Inc. | 189 |
12 |
| io Therapeutics, Inc. | 125 |
11 |
| Santen Pharmaceutical Co., Ltd. | 595 |
11 |
| Clexio Biosciences Ltd. | 100 |
11 |
| F. Hoffmann-La Roche AG | 7815 |
10 |
| The Johns Hopkins University | 5907 |
10 |
| Dana-Farber Cancer Institute, Inc. | 2668 |
10 |
| Immunome Inc. | 71 |
10 |
| Other owners | 1181 |